Table 1

Patient characteristics and clinical details for the overall group and for the two stent subgroups

Characteristics and clinical details Overall
(n=134)
Tannenbaum (n=65) Cotton–Leung (n=69)
Sex
Male
Female

55 (41%)
79 (59%)

31 (48%)
34 (52%)

24 (35%)
45 (65%)
Median (range) age (y)
75.5 (41–90)75 (44–89)76 (41–90)
ASA grade
I
II
III
IV

15 (11%)
93 (69%)
24 (18%)
2 (2%)

6 (9%)
48 (74%)
10 (15%)
1 (2%)

9 (13%)
45 (65%)
14 (20%)
1 (1%)
Diagnosis
Pancreatic cancer
Cholangiocarcinoma
Metastatic nodes
Ampullary cancer
Miscellaneous

94 (70%)
20 (15%)
8 (6%)
7 (5%)
5 (4%)

48 (74%)
12 (18%)
1 (2%)
2 (3%)
2 (3%)

46 (67%)
8 (12%)
7 (10%)
5 (7%)
3 (4%)
Mean serum bilirubin (range) (μmol/l)297.3 (11–828)318.5 (19–828)277.1 (11–627)
Median alkaline phosphatase (range) (IU/l)559 (58.6–3682)471 (93–3682)562 (58.6–2655)